Similar Posts
Don't Let Your Physician Tell You What To Do Without Finding Out Your Goals
A recent study of men with early-stage prostate cancer found no difference in 10-year death rates, regardless of whether their doctors actively monitored the cancers for signs of growth or eradicated the men’s cancers with surgery or radiation. What does this study mean for patients? Based on research we have conducted on prostate cancer decision-making,…
The Cost of New Cancer Drugs (In One Picture)
“Specialty drugs” – that’s what they’re called. Not the pills of old, these pharmaceuticals are often given intravenously or through injection. Often more biologic in their synthesis than chemical, they are expensive to produce and often target narrow disease processes, meaning the number of patients likely to benefit from them is much much smaller than,…
Good and Bad News about Physician Pay
I’ve got some good news for all of you: there’s no racial disparity in pay among female physicians. African-American physicians in the United States make just as much money as Caucasian women. Unfortunately, this good news is largely a result of dismal news – neither group of women make as much as white male physicians….
Reducing Healthcare Waste: Don’t Expect Patients To Take The Lead
Lena Wright’s best friend was hunched over like a character from a French novel, with spinal bones so thin they would fracture with a fit of sneezing. Determined to avoid that fate, Wright (a pseudonym) asked her primary care doctor to test her for osteoporosis with a DEXA scan, also known as Dual Energy X-ray…
How Philosophy Training Helps Me Overcome the Persuasive Power of Advertising
Advertising is about persuasion. Companies spend billions of dollars per year trying to convince us to buy their products. But sometimes, rigorous philosophical training can help us avoid that influence. Consider the following ad: Only deep immersion in Immanuel Kant helped me recognize the flaws in this reasoning!
Is This Enough Competition for You?
Some people look at the figure below, and say that too few insurance companies have too much of the market for Medicare Advantage (a program that allows Medicare recipients to get private coverage). But I look at it and think it looks like a pretty robust market: What do you think?